4-aminomethylbenzoic acid has been researched along with Carcinoma, Transitional Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Ding, GQ; Jin, XD; Lu, J; Shen, ZJ; Shi, SF | 1 |
| Ding, GQ; Pan, CW; Shen, ZJ; Wang, Y; Zheng, RM | 1 |
1 trial(s) available for 4-aminomethylbenzoic acid and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
[Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
Topics: 4-Aminobenzoic Acid; Adjuvants, Immunologic; Administration, Intravesical; Adult; Aged; Aged, 80 and over; Aminocaproic Acid; Antifibrinolytic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Combined Modality Therapy; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; para-Aminobenzoates; Urinary Bladder Neoplasms | 2005 |
1 other study(ies) available for 4-aminomethylbenzoic acid and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Study on enhancement of fibronectin-mediated bacillus Calmette-Guérin attachment to urinary bladder wall in rabbits.
Topics: 4-Aminobenzoic Acid; Administration, Intravesical; Aminocaproic Acid; Animals; Antifibrinolytic Agents; Carcinoma, Transitional Cell; Disease Models, Animal; Fibrinolytic Agents; Fibronectins; Heparin; Male; Mycobacterium bovis; para-Aminobenzoates; Rabbits; Urinary Bladder; Urinary Bladder Neoplasms | 2007 |